S0505 Sorafenib in Treating Patients With Advanced Soft Tissue Sarcomas

NCT00217620 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

51

Enrollment

NIH

Sponsor class

Conditions

Sarcoma

Interventions

DRUG: sorafenib

Sponsor

National Cancer Institute (NCI)